ZEB1 and familial pancreatic carcinoma: Meanwhile, both were found to be overexpressed in pancreatic cancer tissues and high ZEB1 and ELK3 expression were both closely associated with patients’ clinicopathological features and worse overall survival, indicating ZEB1 and ELK3 may be efficient diagnostic and therapeutic targets in PDAC.